Hercules Capital EBITDA Margin 2010-2023 | HTGC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Hercules Capital (HTGC) over the last 10 years. The current EBITDA margin for Hercules Capital as of December 31, 2023 is .
| Hercules Capital EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-12-31 |
$0.46B |
$0.37B |
80.26% |
| 2023-09-30 |
$0.44B |
$0.34B |
78.54% |
| 2023-06-30 |
$0.41B |
$0.32B |
77.78% |
| 2023-03-31 |
$0.36B |
$0.27B |
75.90% |
| 2022-12-31 |
$0.32B |
$0.24B |
74.77% |
| 2022-09-30 |
$0.29B |
$0.21B |
73.04% |
| 2022-06-30 |
$0.28B |
$0.20B |
72.04% |
| 2022-03-31 |
$0.28B |
$0.20B |
72.92% |
| 2021-12-31 |
$0.28B |
$0.21B |
73.31% |
| 2021-09-30 |
$0.28B |
$0.21B |
75.00% |
| 2021-06-30 |
$0.28B |
$0.22B |
76.41% |
| 2021-03-31 |
$0.28B |
$0.22B |
76.95% |
| 2020-12-31 |
$0.29B |
$0.22B |
77.70% |
| 2020-09-30 |
$0.28B |
$0.22B |
77.74% |
| 2020-06-30 |
$0.28B |
$0.22B |
77.66% |
| 2020-03-31 |
$0.28B |
$0.22B |
76.68% |
| 2019-12-31 |
$0.27B |
$0.20B |
76.12% |
| 2019-09-30 |
$0.25B |
$0.19B |
74.80% |
| 2019-06-30 |
$0.24B |
$0.18B |
73.95% |
| 2019-03-31 |
$0.22B |
$0.16B |
73.97% |
| 2018-12-31 |
$0.21B |
$0.15B |
73.68% |
| 2018-09-30 |
$0.20B |
$0.15B |
73.76% |
| 2018-06-30 |
$0.20B |
$0.14B |
73.33% |
| 2018-03-31 |
$0.19B |
$0.14B |
74.09% |
| 2017-12-31 |
$0.19B |
$0.14B |
74.74% |
| 2017-09-30 |
$0.19B |
$0.14B |
74.87% |
| 2017-06-30 |
$0.19B |
$0.14B |
75.27% |
| 2017-03-31 |
$0.18B |
$0.14B |
74.73% |
| 2016-12-31 |
$0.18B |
$0.13B |
73.71% |
| 2016-09-30 |
$0.17B |
$0.12B |
73.65% |
| 2016-06-30 |
$0.17B |
$0.12B |
71.60% |
| 2016-03-31 |
$0.16B |
$0.12B |
70.55% |
| 2015-12-31 |
$0.16B |
$0.11B |
69.87% |
| 2015-09-30 |
$0.15B |
$0.11B |
68.83% |
| 2015-06-30 |
$0.14B |
$0.10B |
70.83% |
| 2015-03-31 |
$0.14B |
$0.10B |
72.86% |
| 2014-12-31 |
$0.14B |
$0.11B |
74.31% |
| 2014-09-30 |
$0.14B |
$0.11B |
77.86% |
| 2014-06-30 |
$0.14B |
$0.11B |
77.08% |
| 2014-03-31 |
$0.15B |
$0.11B |
76.55% |
| 2013-12-31 |
$0.14B |
$0.11B |
77.14% |
| 2013-09-30 |
$0.13B |
$0.09B |
70.15% |
| 2013-06-30 |
$0.12B |
$0.08B |
68.38% |
| 2013-03-31 |
$0.11B |
$0.07B |
66.98% |
| 2012-12-31 |
$0.10B |
$0.06B |
64.95% |
| 2012-09-30 |
$0.09B |
$0.07B |
74.73% |
| 2012-06-30 |
$0.09B |
$0.06B |
74.42% |
| 2012-03-31 |
$0.08B |
$0.06B |
73.49% |
| 2011-12-31 |
$0.08B |
$0.06B |
71.25% |
| 2011-09-30 |
$0.08B |
$0.05B |
71.05% |
| 2011-06-30 |
$0.07B |
$0.05B |
69.86% |
| 2011-03-31 |
$0.07B |
$0.05B |
70.15% |
| 2010-12-31 |
$0.06B |
$0.04B |
70.49% |
| 2010-09-30 |
$0.06B |
$0.04B |
62.30% |
| 2010-06-30 |
$0.06B |
$0.04B |
63.49% |
| 2010-03-31 |
$0.07B |
$0.04B |
64.18% |
| 2009-12-31 |
$0.07B |
$0.05B |
64.86% |
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
Finance - SBIC & Commercial |
$3.131B |
$0.461B |
|
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
|
